Familial factors in the antihypertensive response to lisinopril

Norman K. Hollenberg, Deborah A. Anzalone, Bonita Falkner, Naomi D L Fisher, Paul N. Hopkins, Willa Hsueh, Howard Hutchinson, Ronald M. Krauss, Deborah A. Price, Philip Raskin, Gerald M. Reaven

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: Although it is widely recognized that there are familial elements in the pathogenesis of hypertension, remarkably little is known about the influence of family history on response to specific antihypertensive agents. Methods: This study was designed to address that issue by comparing the depressor response to lisinopril in a dose range of 10 to 40 mg in 74 patients enrolled as sibling pairs. Because all patients were treated with lisinopril, ambulatory blood pressure monitoring (ABPM), an objective measure not influenced by the investigators, was used to assess the primary blood pressure (BP) outcome variable. Results: Diastolic BP was highly correlated between sibling pairs at baseline (r = 0.476; P < .03) and on treatment (r = 0.524: P = .0021). Ethnicity/race had a striking influence on lisinopril dose and response rate. Among African American patients, 23 of 28 reached the top dose of 40 mg/day, whereas only 14 of 36 Caucasian patients reached that dose level. Among Caucasians, 92% responded, and only 48% of African Americans. Responders were characterized by being younger and heavier, having significantly lower microalbuminuria at baseline, higher baseline renal plasma flow (RPF), and higher urinary kallikrein. Conclusion: Among Caucasians, the presence of a hypertensive sibling predicts a striking therapeutic response to angiotensin converting enzyme inhibition.

Original languageEnglish (US)
Pages (from-to)218-223
Number of pages6
JournalAmerican Journal of Hypertension
Volume14
Issue number3
DOIs
StatePublished - 2001

Fingerprint

Lisinopril
Antihypertensive Agents
Siblings
Blood Pressure
African Americans
Renal Plasma Flow
Tissue Kallikreins
Ambulatory Blood Pressure Monitoring
Peptidyl-Dipeptidase A
Research Personnel
Hypertension
Therapeutics

Keywords

  • ACE inhibition
  • Ethnicity
  • Genetics
  • Nonmodulators
  • Renin system

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Hollenberg, N. K., Anzalone, D. A., Falkner, B., Fisher, N. D. L., Hopkins, P. N., Hsueh, W., ... Reaven, G. M. (2001). Familial factors in the antihypertensive response to lisinopril. American Journal of Hypertension, 14(3), 218-223. https://doi.org/10.1016/S0895-7061(00)01251-6

Familial factors in the antihypertensive response to lisinopril. / Hollenberg, Norman K.; Anzalone, Deborah A.; Falkner, Bonita; Fisher, Naomi D L; Hopkins, Paul N.; Hsueh, Willa; Hutchinson, Howard; Krauss, Ronald M.; Price, Deborah A.; Raskin, Philip; Reaven, Gerald M.

In: American Journal of Hypertension, Vol. 14, No. 3, 2001, p. 218-223.

Research output: Contribution to journalArticle

Hollenberg, NK, Anzalone, DA, Falkner, B, Fisher, NDL, Hopkins, PN, Hsueh, W, Hutchinson, H, Krauss, RM, Price, DA, Raskin, P & Reaven, GM 2001, 'Familial factors in the antihypertensive response to lisinopril', American Journal of Hypertension, vol. 14, no. 3, pp. 218-223. https://doi.org/10.1016/S0895-7061(00)01251-6
Hollenberg NK, Anzalone DA, Falkner B, Fisher NDL, Hopkins PN, Hsueh W et al. Familial factors in the antihypertensive response to lisinopril. American Journal of Hypertension. 2001;14(3):218-223. https://doi.org/10.1016/S0895-7061(00)01251-6
Hollenberg, Norman K. ; Anzalone, Deborah A. ; Falkner, Bonita ; Fisher, Naomi D L ; Hopkins, Paul N. ; Hsueh, Willa ; Hutchinson, Howard ; Krauss, Ronald M. ; Price, Deborah A. ; Raskin, Philip ; Reaven, Gerald M. / Familial factors in the antihypertensive response to lisinopril. In: American Journal of Hypertension. 2001 ; Vol. 14, No. 3. pp. 218-223.
@article{b7ea6f90d87a4c0baffd37a6c3d2f768,
title = "Familial factors in the antihypertensive response to lisinopril",
abstract = "Background: Although it is widely recognized that there are familial elements in the pathogenesis of hypertension, remarkably little is known about the influence of family history on response to specific antihypertensive agents. Methods: This study was designed to address that issue by comparing the depressor response to lisinopril in a dose range of 10 to 40 mg in 74 patients enrolled as sibling pairs. Because all patients were treated with lisinopril, ambulatory blood pressure monitoring (ABPM), an objective measure not influenced by the investigators, was used to assess the primary blood pressure (BP) outcome variable. Results: Diastolic BP was highly correlated between sibling pairs at baseline (r = 0.476; P < .03) and on treatment (r = 0.524: P = .0021). Ethnicity/race had a striking influence on lisinopril dose and response rate. Among African American patients, 23 of 28 reached the top dose of 40 mg/day, whereas only 14 of 36 Caucasian patients reached that dose level. Among Caucasians, 92{\%} responded, and only 48{\%} of African Americans. Responders were characterized by being younger and heavier, having significantly lower microalbuminuria at baseline, higher baseline renal plasma flow (RPF), and higher urinary kallikrein. Conclusion: Among Caucasians, the presence of a hypertensive sibling predicts a striking therapeutic response to angiotensin converting enzyme inhibition.",
keywords = "ACE inhibition, Ethnicity, Genetics, Nonmodulators, Renin system",
author = "Hollenberg, {Norman K.} and Anzalone, {Deborah A.} and Bonita Falkner and Fisher, {Naomi D L} and Hopkins, {Paul N.} and Willa Hsueh and Howard Hutchinson and Krauss, {Ronald M.} and Price, {Deborah A.} and Philip Raskin and Reaven, {Gerald M.}",
year = "2001",
doi = "10.1016/S0895-7061(00)01251-6",
language = "English (US)",
volume = "14",
pages = "218--223",
journal = "Journal of clinical hypertension",
issn = "0895-7061",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - Familial factors in the antihypertensive response to lisinopril

AU - Hollenberg, Norman K.

AU - Anzalone, Deborah A.

AU - Falkner, Bonita

AU - Fisher, Naomi D L

AU - Hopkins, Paul N.

AU - Hsueh, Willa

AU - Hutchinson, Howard

AU - Krauss, Ronald M.

AU - Price, Deborah A.

AU - Raskin, Philip

AU - Reaven, Gerald M.

PY - 2001

Y1 - 2001

N2 - Background: Although it is widely recognized that there are familial elements in the pathogenesis of hypertension, remarkably little is known about the influence of family history on response to specific antihypertensive agents. Methods: This study was designed to address that issue by comparing the depressor response to lisinopril in a dose range of 10 to 40 mg in 74 patients enrolled as sibling pairs. Because all patients were treated with lisinopril, ambulatory blood pressure monitoring (ABPM), an objective measure not influenced by the investigators, was used to assess the primary blood pressure (BP) outcome variable. Results: Diastolic BP was highly correlated between sibling pairs at baseline (r = 0.476; P < .03) and on treatment (r = 0.524: P = .0021). Ethnicity/race had a striking influence on lisinopril dose and response rate. Among African American patients, 23 of 28 reached the top dose of 40 mg/day, whereas only 14 of 36 Caucasian patients reached that dose level. Among Caucasians, 92% responded, and only 48% of African Americans. Responders were characterized by being younger and heavier, having significantly lower microalbuminuria at baseline, higher baseline renal plasma flow (RPF), and higher urinary kallikrein. Conclusion: Among Caucasians, the presence of a hypertensive sibling predicts a striking therapeutic response to angiotensin converting enzyme inhibition.

AB - Background: Although it is widely recognized that there are familial elements in the pathogenesis of hypertension, remarkably little is known about the influence of family history on response to specific antihypertensive agents. Methods: This study was designed to address that issue by comparing the depressor response to lisinopril in a dose range of 10 to 40 mg in 74 patients enrolled as sibling pairs. Because all patients were treated with lisinopril, ambulatory blood pressure monitoring (ABPM), an objective measure not influenced by the investigators, was used to assess the primary blood pressure (BP) outcome variable. Results: Diastolic BP was highly correlated between sibling pairs at baseline (r = 0.476; P < .03) and on treatment (r = 0.524: P = .0021). Ethnicity/race had a striking influence on lisinopril dose and response rate. Among African American patients, 23 of 28 reached the top dose of 40 mg/day, whereas only 14 of 36 Caucasian patients reached that dose level. Among Caucasians, 92% responded, and only 48% of African Americans. Responders were characterized by being younger and heavier, having significantly lower microalbuminuria at baseline, higher baseline renal plasma flow (RPF), and higher urinary kallikrein. Conclusion: Among Caucasians, the presence of a hypertensive sibling predicts a striking therapeutic response to angiotensin converting enzyme inhibition.

KW - ACE inhibition

KW - Ethnicity

KW - Genetics

KW - Nonmodulators

KW - Renin system

UR - http://www.scopus.com/inward/record.url?scp=0035092285&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035092285&partnerID=8YFLogxK

U2 - 10.1016/S0895-7061(00)01251-6

DO - 10.1016/S0895-7061(00)01251-6

M3 - Article

C2 - 11281232

AN - SCOPUS:0035092285

VL - 14

SP - 218

EP - 223

JO - Journal of clinical hypertension

JF - Journal of clinical hypertension

SN - 0895-7061

IS - 3

ER -